Younger age as a bad prognostic factor in patients with carcinoma of the cervix

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 64, Issue 2, 1996, Pages 201-205

  Delaloye, Jean F ^a   Pampallona, Sandro ^a   Coucke, Philippe A ^a   De Grandi, Pierre ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Age; Cervix carcinoma; Overall survival

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; SWITZERLAND; UTERINE CERVIX CARCINOMA;

EID: 0030022645     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/0301-2115(95)02290-2     Document Type: Article

References (44)

1. Lindell A. Carcinoma of the uterine cervix: Incidence and influence of age. A statistical study. Acta Radiol 1952; 92 (Suppl): 1-102.
2. Kottmeier HL. Surgical and radiation treatment of carcinoma fo the uterine cervix. Acta Obstet Gynecol Scand 1964; 43 (Suppl 2): 1-49.
3. Stanhope CR, Smith JP, Wharton JT, Rutledge FN, Fletcher GH, Gallagher HS. Carcinoma of the cervix. The effect of age on survival. Gynecol Oncol 1980; 10: 188193.
4. Gynning I, Johnsson JE, Alm P, Tropé C. Age and prognosis in stage Ib squamous cell carcinoma of the cervix. Gynecol Oncol 1982; 15: 18-26.
5. Prempree T, Patanaphan V, Sewshand W, Scott RM. The influence of patients' age and tumor grade on the prognosis of carcinoma of the cervix. Cancer 1983; 51: 1764-1771.
6. Lybeert MLM, Meerwaldt JH, van Putten WLJ. Age as a prognostic factor in carcinoma of the cervix. Radiother Oncol 1987; 9: 147-151.
7. Elliott PM, Tattersall MHN, Coppleson M, Russell P, Coates AS, Solomon HJ. Changing character of cervical cancer in young women [letter]. Br Med J 1989; 298: 288.
8. Dattoli MJ, Gretz HF, Beller Z et al. Analysis of multiple prognostic factors in patients with stage IB cervical cancer: Age as a major determinant. Int J Radiat Oncol Biol Phys 1989; 17: 41-47.
9. Lee YN, Wang KL, Lin MH et al. Radical hysterectomy with pelvic lymph node dissection for treatment of cervical cancer. A clinical review of 954 cases. Gynecol Oncol 1989; 32: 135-142.
10. Maddux HR, Varia MA, Spann CO, Fowler WC, Rosenman JG. Invasive carcinoma of the uterine cervix in women of age 25 or less. Int J Radiat Oncol Biol Phys 1990; 19: 701-706.
11. Clark MA, Naahas W, Markert RJ, Dodson MG. Cervical cancer: Women aged 35 and younger compared to women aged 36 and older. Am J Clin Oncol 1991; 14: 352-356.
12. Kodama S, Kanasawa K, Honna S, Tanaka K. Age as a prognostic factor in patients with squamous cell carcinoma of the uterine cervix. Cancer, 1991; 68: 2481-2485.
13. Rutledge FN, Mitchell MF, Munsell M, Bass S, Mc Guffee V, Atkins EN. Youth as a prognostic factor in carcinoma of the cervix: a matched analysis. Gynecol Oncol 1992; 44: 123-130.
14. Robertson D, Fedorkow DM, Stuart GCE, Mc Gregor SE. Age as a prognostic variable in cervical squamous cell carcinoma. Eur J Gynaecol Oncol 1993; 14: 283-291.
15. Dodds JR, Latour JP. Relationship of age to survival rate in carcinoma of the cervix. Am J Obstet Gynecol 1961; 82: 33-36.
16. Decker DG, Fricke RE, Pratt JH. Invasive carcinoma of the cervix in young women. JAMA 1955; 158: 1417-1420.
17. Kyriakos M, Kempson RL, Perez CA. Carcinoma of the cervix in young women. Obstet Gynecol 1971; 38: 930-944.
18. Kjørstad KE. Carcinoma of the cervix in the young patient. Obstet Gynecol 1977; 50: 28-30.
19. Baltzer J, Koepcke W, Lohe KJ, Ober KG, Zander J. Age and 5-year survival rates in patients with operated carcinoma of the cervix. Gynecol Oncol 1982; 14: 220-224.
20. Carmichael JA, Clark DH, Moher D, Ohlke ID, Karchmar EJ. Cervical carcinoma in women aged 34 and younger. Am J Obstet Gynecol 1986; 154: 264-269.
21. Meanwell CA, Kelly KA, Wilson S et al. Young age as a prognostic factor in cervical cancer. Analysis of population based data from 10 022 cases. Br Med J 1988; 296: 386-391.
22. Spanos WK, King A, Keeney E, Wagner R, Slater JM. Age as a prognostic factor in carcinoma of the cervix. Gynecol Oncol 1989; 35: 66-68.
23. Junor EJ, Symonds RP, Whatson ER, Lamont DW. Survival of younger cervical carcinoma patients treated by radical radiotherapy in the West of Scotland 1964-1984. Br J Obstet Gynecol 1989; 96: 522-528.
24. Fyles A, Keane TJ, Barton MB, Simm J. The effect of treatment duration in the local control of cervix cancer. Radiother Oncol 1992; 25: 273-279.
25. Lanciano RM, Pajak TF, Martz K, Hanks GE. The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: A patterns-of-care study. Int J Radiat Oncol Biol Phys 1993; 25: 391-397.
26. Girinsky T, Rey A, Roche B et al. Overall treatment time in advanced cervical carcinomas: A critical parameter in treatment outcome. Int. J. Radiat. Oncol. Biol. Phys. 1993, 27, 1051-1056.
27. Stata. Computing Resource Center Reference Manual, 1991
28. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
29. Greenwood M. Reports on public health and medical subjects: The natural duration of cancer. HMSO 1926; 33: 1-16.
30. Peto R, Pike M.C, Armitage P et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977; 35: 1-39.
31. Cox DR. Regression models and life tables. J R Stat Soc B 1972; 34: 187-220.
32. Armitage P, Berry G. Statistical methods in medical research (2nd. ed.). Oxford: Blackwell, 1987.
33. Stellato G, Tikkala L, Kajanoja P. Invasive cervical carcinoma in patients ages 35 or younger. Eur J Gynaecol Oncol 1992; 13: 490-493.
34. Cancer incidence in five continents. IARC Scientific Publications 1992; 120: 25-30.
35. Sebbelov AM, Kjørstad KE, Abeler VM. Norrild B. The prevalence of human papillomavirus type 16 and 18 DNA in cervical cancer in different age groups: A study on the incidental cases of cervical cancer in Norway in 1983. Gynecol Oncol 1991; 41: 141-148.
36. West CML, Davidson SE, Burt PA, Hunter RD. The intrinsic radiosensitivity of cervical carcinoma: correlation with clinical data. Int J Radiat Oncol Biol Phys 1995; 31: 841.
37. Kerr JFR, Winterford CM., Harmon BV. Apoptosis. Its significance in cancer and cancer therapy. Cancer 1994; 73: 2013.
38. Levine EL, Davidson SE, Roberts SA, Chadwick CA, Potten CS, West CML. Apoptosis as predictor of response to radiotherapy in cervical carcinoma. Lancet 1994; 344: 472.
39. Steck KD, McDonnell TJ, El-Naggar AK. Flow cytometric analysis of apoptosis and BCL-2 in human solid neoplasms. Cytometry 1995; 20: 154-161.
40. Chen M, Quintans J, Thompson C, Kufe DW, Weichselbaum RR. Suppression of Bcl-2 messenger RNA production may mediate apoptosis after after ionizing radiation, tumor necrosis factor a, and ceramide. Cancer Research 1995; 55: 991-994.
41. Lowe SW, Bodis S, McClatchey A et al. p53 status and the efficacy of cancer therapy in vivo. Science 1994; 266: 807-810.
42. Eustace D, Han X, Rowbottom A, Riches P, Heyderman E. Interleukin-6 (IL-6) function as an autocrine growth factor in cervical carcinomas in vitro. Gynecol Oncol 1993; 50: 15-19.
43. Konski A, Domenico D, Irwing D et al. Flow cytometric DNA content analysis of paraffin-embedded tissue derived from cervical carcinoma. Int J Radiat Oncol Biol Phys 1994; 30: 839-843.
44. Withers HR. Treatment induced accelerated human tumor-growth. Semin Radiat Oncol 1993; 3: 135-141.